Skip to main content
. 2017 Jun 21;6(6):e005477. doi: 10.1161/JAHA.117.005477

Table 2.

Clinical and Anthropometric Characteristics of Participants Stratified by Race and Sex

Men Women
White (n=2850) Brown (n=1682) Black (n=774) P for Race White (n=3323) Brown (n=1682) Black (n=1161) P for Race
Age, y 52.6±9.4 50.5±8.5a 51.5±8.5a, b <0.001 52.3±9.0 51.5±8.5a 51.6±8.5a 0.006
Weight, kg 80.6±13.9 78.3±14.8a 80.8±15.2b <0.001 67.3±13.1 68.0±12.9 72.1±14.5a, b <0.001
Height, cm 173.0±7.0 171.0±7.1a 171.8±7.3a, b <0.001 159.6±6.5 158.4±6.3a 159.1±6.3b <0.001
BMI, kg/m2 26.9±4.2 26.7±4.3 27.3±4.5b 0.002 26.4±4.8 27.1±4.8a 28.5±5.5a, b <0.001
WC, cm 95.8±11.5 94.1±11.4a 94.8±12.0 <0.001 86.3±12.2 88.0±12.0a 90.6±13.0a, b <0.001
Uric acid, mmol/L 0.382±0.079 0.382±0.088 0.381±0.087 0.420 0.282±0.068 0.282±0.070 0.291±0.075a, b 0.009
Glucose, mmol/L 6.30±1.55 6.44±1.89a 6.71±2.34a, b 0.019 5.85±1.20 5.99±1.54a 6.20±1.87a, b <0.001
HbA1C, % 5.39±0.86 5.52±1.08a 5.78±1.31a, b <0.001 5.32±0.76 5.46±0.89a 5.68±1.11a, b <0.001
Cholesterol, mmol/L 5.49±1.07 5.56±1.13 5.62±1.19a 0.032 5.63±1.05 5.65±1.08 5.52±1.11a, b <0.001
LDL‐c, mmol/L 3.38±0.88 3.43±0.94 3.45±1.04 0.338 3.39±0.89 3.46±0.90 3.35±0.90b 0.004
HDL‐c, mmol/L 1.31±0.30 1.31±0.31 1.39±0.36a, b <0.001 1.62±0.38 1.57±0.37a 1.59±0.37 <0.001
TG, mmol/L 1.80±1.24 1.91±1.69a 1.81±1.49 0.165 1.36±0.87 1.37±0.82 1.26±1.23a, b <0.001
eGFR, mL/min per 1.73 m2 82.0±15.3 83.1±14.8a 80.5±15.0a, b <0.001 101.3±12.4 102.3±12.1a 100.3±13.2b 0.002
Salt intake, g/day 12.3±5.3 13.2±6.3a 13.7±6.6a <0.001 9.1±4.1 9.5±4.5 10.0±4.8a, b <0.001
C‐RP, UI 2.32±3.52 2.72±5.47a 2.91±4.80a <0.001 2.88±4.10 3.25±4.82a 3.81±5.61a, b <0.001
SAP, mm Hg 122.9±15.2 127.0±17.0a 132.1±19.0a, b <0.001 114.9±15.3 118.6±17.1a 123.3±18.8a, b <0.001
DAP, mm Hg 77.6±10.1 80.1±11.0a 82.5±11.6a, b <0.001 72.4±9.7 74.7±10.3a 77.3±10.6a, b <0.001
MAP, mm Hg 92.7±11.2 95.8±12.4a 99.0±13.3a, b <0.001 86.5±11.0 89.3±11.9a 92.7±12.6a, b <0.001
HR, bpm 69.6±10.6 69.5±10.9 68.7±11.0 0.134 71.7±9.6 70.2±9.8a 70.2±10.1a <0.001
cf‐PWV, m/s 9.63±1.81 9.63±1.87 9.98±1.99a, b <0.001 8.84±1.65 9.02±1.66a 9.34±1.91a, b <0.001
cf‐PWV quartiles, n,%
Q1 739 (55) 446 (33.2) 158 (11.8) <0.001 959 (59.9) 408 (25.5) 234 (14.6) <0.001
Q2 788 (54.4) 476 (32.8) 185 (12.8) <0.001 892 (55.4) 446 (27.7) 271 (16.8) <0.001
Q3 654 (53.9) 368 (30.3) 191 (15.8) <0.001 788 (53.2) 402 (27.2) 290 (19.6) <0.001
Q4 669 (51.4) 392 (30.1) 240 (18.5) <0.001 684 (46.3) 426 (28.9) 366 (24.8) <0.001
Hypertension, n,% 984 (34.5) 655 (38.9) 386 (49.9) <0.001c 823 (24.8) 554 (32.9) 538 (46.3) <0.001c
BP lowering drugs, n, % 770 (27) 423 (25.1) 255 (32.9) 0.029c 767 (23.1) 483 (28.7) 445 (38.3) <0.001c
Diabetes mellitus, n, % 559 (19.6) 377 (22.4) 228 (29.4) <0.001c 418 (12.6) 273 (16.2) 291 (25.1) <0.001c
Glucose lowering drugs, n, % 225 (7.9) 125 (7.4) 99 (12.8) 0.001c 180 (5.4) 128 (7.6) 117 (10.1) <0.001c
Obesity, n, % 555 (19.5) 336 (20) 179 (23.1) 0.045c 687 (20.7) 407 (24.2) 406 (35) <0.001c

BMI indicates body mass index; cf‐PWV, carotid‐femoral pulse wave velocity; CRP, C‐reactive protein; DAP, diastolic arterial pressure; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL‐c, high‐density lipoprotein cholesterol; HR, heart rate; LDL‐c, low‐density lipoprotein cholesterol; MAP, mean arterial pressure; Q, quartile; BP, blood pressure; SAP, systolic arterial pressure; TG, triglycerides; WC, waist circumference.

a

P<0.05 vs white.

b

P<0.05 vs brown.

c

Represents P value for trend.